{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:57:38Z","timestamp":1789178258910,"version":"build-2803163510"},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,1]]},"DOI":"10.1093\/qjmed\/hcaf258","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:26:22Z","timestamp":1761222382000},"page":"166-168","source":"Crossref","is-referenced-by-count":2,"title":["Immune checkpoint inhibitor-related haemophagocytic lymphohistiocytosis (HLH) in triple negative breast cancer: a case series"],"prefix":"10.1093","volume":"119","author":[{"given":"Tim","family":"Cooksley","sequence":"first","affiliation":[{"name":"Department of Acute Oncology, The Christie , Manchester,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie M J","family":"Weaver","sequence":"additional","affiliation":[{"name":"Department of Acute Oncology, The Christie , Manchester,","place":["UK"]},{"name":"Department of Medical Oncology, The Christie , Manchester,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bence","family":"Nagy","sequence":"additional","affiliation":[{"name":"Department of Acute Oncology, The Christie , Manchester,","place":["UK"]},{"name":"Department of Medical Oncology, The Christie , Manchester,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, The Christie , Manchester,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,25]]},"reference":[{"key":"2026032819425150700_hcaf258-B1","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2409932","article-title":"Overall survival with pembrolizumab in Early-Stage Triple-Negative breast cancer","volume":"391","author":"Schmid","year":"2024","journal-title":"N Engl J Med"},{"key":"2026032819425150700_hcaf258-B2","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2026032819425150700_hcaf258-B3","doi-asserted-by":"crossref","first-page":"102896","DOI":"10.1016\/j.bcmd.2024.102896","article-title":"Hemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitor use: a review of the current knowledge and future directions","volume":"110","author":"Walmsley","year":"2025","journal-title":"Blood Cells Mol Dis"},{"key":"2026032819425150700_hcaf258-B4","doi-asserted-by":"crossref","first-page":"e002435","DOI":"10.1136\/jitc-2021-002435","article-title":"Society for immunotherapy of cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events","volume":"9","author":"Brahmer","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2026032819425150700_hcaf258-B5","doi-asserted-by":"crossref","DOI":"10.1007\/s00404-025-08078-4","article-title":"Secondary hemophagocytic lymphohistiocytosis associated with adjuvant pembrolizumab therapy in a young patient with triple-negative breast cancer: a case report with literature review","author":"Olmes","year":"2025","journal-title":"Arch Gynecol Obstet"},{"key":"2026032819425150700_hcaf258-B6","doi-asserted-by":"crossref","first-page":"104536","DOI":"10.1016\/j.breast.2025.104536","article-title":"Acute presentations in neoadjuvant chemotherapy\/immune checkpoint inhibition for triple negative breast cancer: experiences and impact from real-world data","volume":"83","author":"Cooksley","year":"2025","journal-title":"Breast"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/qjmed\/advance-article-pdf\/doi\/10.1093\/qjmed\/hcaf258\/64943966\/hcaf258.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/119\/2\/166\/64943966\/hcaf258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/119\/2\/166\/64943966\/hcaf258.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T23:42:59Z","timestamp":1774741379000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article\/119\/2\/166\/8301307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":6,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,10,25]]},"published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcaf258","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,10,25]]}}}